• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SUD
Click for more information
0.00% 4.2¢

SUDA PHARMACEUTICALS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
SUD Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
SUD Suda Enters Into Licence Agreement With AmherstPRICE SENSITIVE08/01/15
SUD Appendix 4C - quarterlyPRICE SENSITIVE30/10/14
SUD Preliminary Final ReportPRICE SENSITIVE29/08/14
SUD Update On ArTiMistPRICE SENSITIVE21/08/14
SUD Appendix 4C - quarterlyPRICE SENSITIVE24/07/14
SUD Bergen FundingPRICE SENSITIVE15/07/14
SUD Underwriting of OptionsPRICE SENSITIVE01/07/14
SUDWestcoast Expands To East CoastPRICE SENSITIVE01/05/14
SUDAppendix 4C - quarterlyPRICE SENSITIVE30/04/14
SUDShareholder UpdatePRICE SENSITIVE01/04/14
SUDAppendix 4D Half Year Ended 31 December 2013PRICE SENSITIVE26/02/14
SUDAppendix 4C - quarterlyPRICE SENSITIVE23/01/14
SUDWestcoast Expands Aged Care ActivitiesPRICE SENSITIVE22/01/14
SUDWestcoast Launches Novel Hemostyp GauzePRICE SENSITIVE15/01/14
SUDBergen Funding PostponedPRICE SENSITIVE09/12/13
SUDSuda Completes Successful $5.6m Capital RaisingPRICE SENSITIVE13/11/13
SUDTrading HaltPRICE SENSITIVE11/11/13
SUDSuda Retains Leading Life Sciences Advisory FirmPRICE SENSITIVE11/11/13
SUDAppendix 4C - quarterlyPRICE SENSITIVE21/10/13
SUDSuda's Subsidiary Achieves Record First Quarter ResultsPRICE SENSITIVE18/10/13
SUDSuda Completes $1.9m Secured Convertible Note IssuePRICE SENSITIVE16/09/13
SUDPreliminary Final ReportPRICE SENSITIVE30/08/13
SUDSuda's Subsidiary Wins Major TenderPRICE SENSITIVE15/08/13
SUDAppendix 4C - quarterlyPRICE SENSITIVE31/07/13
SUDOutstanding Results Confirmed in ArTiMist Final ReportPRICE SENSITIVE30/07/13
SUDNovaDel Shareholders Approve Suda Acquisition of AssetsPRICE SENSITIVE23/07/13
SUDTrading HaltPRICE SENSITIVE22/07/13
SUDOutstanding Preliminary results from ArTiMist Phase 3 trialPRICE SENSITIVE30/04/13
SUDTrading HaltPRICE SENSITIVE29/04/13
SUDManufacturing UpdatePRICE SENSITIVE16/04/13
SUDSUDA sign Sale and Purchase Agreement with NovadelPRICE SENSITIVE08/04/13
SUDAppendix 4D Half Year Ended 31 December 2012PRICE SENSITIVE27/02/13
SUDCompany UpdatePRICE SENSITIVE04/02/13
SUDAppendix 4C - quarterlyPRICE SENSITIVE31/01/13
SUDSUDA Signs Option To Acquire NovaMist TechnologyPRICE SENSITIVE20/12/12
SUDTrading HaltPRICE SENSITIVE19/12/12
SUDSuda Ltd Secures up to $7.6m Project FundingPRICE SENSITIVE10/12/12
SUD Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
SUD Suda Enters Into Licence Agreement With Amherst
08/01/15PRICE SENSITIVE
SUD Appendix 4C - quarterly
30/10/14PRICE SENSITIVE
SUD Preliminary Final Report
29/08/14PRICE SENSITIVE
SUD Update On ArTiMist
21/08/14PRICE SENSITIVE
SUD Appendix 4C - quarterly
24/07/14PRICE SENSITIVE
SUD Bergen Funding
15/07/14PRICE SENSITIVE
SUD Underwriting of Options
01/07/14PRICE SENSITIVE
SUDWestcoast Expands To East Coast
01/05/14PRICE SENSITIVE
SUDAppendix 4C - quarterly
30/04/14PRICE SENSITIVE
SUDShareholder Update
01/04/14PRICE SENSITIVE
SUDAppendix 4D Half Year Ended 31 December 2013
26/02/14PRICE SENSITIVE
SUDAppendix 4C - quarterly
23/01/14PRICE SENSITIVE
SUDWestcoast Expands Aged Care Activities
22/01/14PRICE SENSITIVE
SUDWestcoast Launches Novel Hemostyp Gauze
15/01/14PRICE SENSITIVE
SUDBergen Funding Postponed
09/12/13PRICE SENSITIVE
SUDSuda Completes Successful $5.6m Capital Raising
13/11/13PRICE SENSITIVE
SUDTrading Halt
11/11/13PRICE SENSITIVE
SUDSuda Retains Leading Life Sciences Advisory Firm
11/11/13PRICE SENSITIVE
SUDAppendix 4C - quarterly
21/10/13PRICE SENSITIVE
SUDSuda's Subsidiary Achieves Record First Quarter Results
18/10/13PRICE SENSITIVE
SUDSuda Completes $1.9m Secured Convertible Note Issue
16/09/13PRICE SENSITIVE
SUDPreliminary Final Report
30/08/13PRICE SENSITIVE
SUDSuda's Subsidiary Wins Major Tender
15/08/13PRICE SENSITIVE
SUDAppendix 4C - quarterly
31/07/13PRICE SENSITIVE
SUDOutstanding Results Confirmed in ArTiMist Final Report
30/07/13PRICE SENSITIVE
SUDNovaDel Shareholders Approve Suda Acquisition of Assets
23/07/13PRICE SENSITIVE
SUDTrading Halt
22/07/13PRICE SENSITIVE
SUDOutstanding Preliminary results from ArTiMist Phase 3 trial
30/04/13PRICE SENSITIVE
SUDTrading Halt
29/04/13PRICE SENSITIVE
SUDManufacturing Update
16/04/13PRICE SENSITIVE
SUDSUDA sign Sale and Purchase Agreement with Novadel
08/04/13PRICE SENSITIVE
SUDAppendix 4D Half Year Ended 31 December 2012
27/02/13PRICE SENSITIVE
SUDCompany Update
04/02/13PRICE SENSITIVE
SUDAppendix 4C - quarterly
31/01/13PRICE SENSITIVE
SUDSUDA Signs Option To Acquire NovaMist Technology
20/12/12PRICE SENSITIVE
SUDTrading Halt
19/12/12PRICE SENSITIVE
SUDSuda Ltd Secures up to $7.6m Project Funding
10/12/12PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Riversgold notes strong intercepts at Northern Zone in AC campaign

Riversgold Ltd has completed its fourth round of aircore drilling at the Northern Zone Gold Project for 2024
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.